Skip to main content
. 2021 Nov 5;4(4):e29049. doi: 10.2196/29049

Table 4.

Treatments and complications during hospital stay. 

Total cohort (N=111) Asymptomatic (n=43) Symptomatic (n=68) P value
Treatment, n (%) 

Hydroxychloroquine  17 (15.3)  5 (11.6)  12 (17.6)   .28

Azithromycin 4 (3.6) 2 (4.7) 2 (2.9) .50

Antibiotics 6 (5.4) 3 (7) 3 (4.4) .16

Lopinavir-ritonavir 1 (0.9) 0 (0) 1 (1.5) .61

Steroids 1 (0.9) 0 (0) 1 (1.5) .61
Complications

Pneumonia, n (%) 3 (2.7) 0 (0) 3 (100) N/A

Duration of hospitalization days, median (range) 8 (0-30) 7 (1-25) 9 (0-30) .19
Outcome, n (%)

Discharge 111 (100) 43 68 N/Aa

Deaths 0 (0) 0 (0) 0 (0) N/A

aN/A: not applicable